DLPRF yields 956.94% · PFE yields 6.13%● Live data
📍 DLPRF pulled ahead of the other in Year 1
Combined, DLPRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLPRF + PFE for your $10,000?
DLP Resources Inc., a mineral exploration company, engages in the acquisition, exploration, and development of mineral properties in British Columbia, Canada. It explores for lead, zinc, copper, and cobalt deposits. The company holds interests in the Aldridge 1 and 2 project consists of fourteen mineral claims within two blocks covering a collective 47.69 square kilometers located on the southwest of Cranbrook; the Hungry Creek property that consists of 11 claims covering an area of 42.62 square kilometers located on the west of Kimberley; the Redburn Creek property comprising 12 claims blocks covering an area of 53.6 square kilometers located in the northeast of Golden; the DD-Panda-Moby Dick and NZOU properties located in the Purcell range of the Columbia Mountains; and the Aurora is a porphyry copper-molybdenum project covering an area of 400 hectares located in the Southern Peru. The company was formerly known as MG Capital Corporation and changed its name to DLP Resources Inc. in January 2021. The company is headquartered in Cranbrook, Canada.
Full DLPRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.